| Literature DB >> 24528817 |
E Mayson1, J Saverimuttu, P Warburton.
Abstract
Haemophagocytic lymphohistiocytosis (HLH) is a rare but potentially fatal disease of children and adults. Cytokine dysfunction, uncontrolled accumulation of activated T-cells and histiocytes, and the inability to terminate the immune response lead to the clinical manifestations of extreme inflammation and end-organ damage. HLH is notoriously underreported because of its ability to mimic many other common diseases. Here, we outline two cases of HLH, one primary and the other secondary, to highlight some of the differences and to discuss therapeutic principles and emerging concepts.Entities:
Keywords: Haemophagocytic lymphohistiocytosis; anaplastic large cell lymphoma; immunology; lymphoma; lymphoproliferative neoplasm
Mesh:
Substances:
Year: 2014 PMID: 24528817 DOI: 10.1111/imj.12347
Source DB: PubMed Journal: Intern Med J ISSN: 1444-0903 Impact factor: 2.048